VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
VERU INC.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$2.31+0.01 (+0.43%)
Close on Oct 19, 2026
- Market cap
- $53.25M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$1.80 (−43.80%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $53.25M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.88
- Dividend yield
- –
- Free cash flow yield
- -48.91%
Fundamentals
- Net income
- -$13.61M
- EPS, diluted
- -$0.58
- Free cash flow
- -$26.04M
- Book value per share
- $1.23
- Diluted shares
- 23M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
-$19.19M
Net income
-$13.61M
EPS, diluted
-$0.58
Free cash flow
-$26.04M
Reported periodTrailing twelve months